Literature DB >> 6691816

Changes in the incidence of amyotrophic lateral sclerosis in Israel.

E Kahana, N Zilber.   

Abstract

The incidence of amyotrophic lateral sclerosis (ALS) in Israel was determined for the period 1959 through 1974. A total of 246 patients with ALS was ascertained. The male-female ratio was 1.62:1. The average annual age-adjusted incidence per 100,000 persons increased during this period by 41%. The increase was almost entirely due to a higher rate in persons more than 60 years of age and was greater in women than in men. This led to a decrease in the male-female ratio. The mean age of onset increased from 52.8 to 58.6 years during the same period. The increment in incidence could not be explained by better case ascertainment or increased life expectancy, but greater precision in diagnosis of ALS in the aged may have partially contributed to the increase.

Entities:  

Mesh:

Year:  1984        PMID: 6691816     DOI: 10.1001/archneur.1984.04050140055023

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  10 in total

1.  Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950.

Authors:  A M Chancellor; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

Review 2.  Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.

Authors:  Benoît Marin; Giancarlo Logroscino; Farid Boumédiene; Anaïs Labrunie; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Pierre Marie Preux; Ettore Beghi
Journal:  Eur J Epidemiol       Date:  2015-10-12       Impact factor: 8.082

3.  The epidemiology of motor neurone disease in two counties in the southwest of England.

Authors:  Ibrahim Imam; Susan Ball; Dave Wright; C Oliver Hanemann; John Zajicek
Journal:  J Neurol       Date:  2010-01-22       Impact factor: 4.849

4.  Amyotrophic lateral sclerosis in Palermo, Italy: an epidemiological study.

Authors:  G Salemi; B Fierro; A Arcara; M Cassata; M G Castiglione; G Savettieri
Journal:  Ital J Neurol Sci       Date:  1989-10

5.  Temporal trend of amyotrophic lateral sclerosis incidence in southern Europe: a population study in the health district of Ferrara, Italy.

Authors:  Vittorio Govoni; Edward Cesnik; Ilaria Casetta; Valeria Tugnoli; Maria Rosaria Tola; Enrico Granieri
Journal:  J Neurol       Date:  2012-01-10       Impact factor: 4.849

6.  Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study.

Authors:  G Logroscino; E Beghi; S Zoccolella; R Palagano; A Fraddosio; I L Simone; P Lamberti; V Lepore; L Serlenga
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08       Impact factor: 10.154

7.  Phenotypic differences of amyotrophic lateral sclerosis (ALS) in China and Germany.

Authors:  Angela Rosenbohm; Mingsheng Liu; Gabriele Nagel; Raphael S Peter; Bo Cui; Xiaoguang Li; Jan Kassubek; Dietrich Rothenbacher; Dorothée Lulé; Liying Cui; Albert C Ludolph
Journal:  J Neurol       Date:  2018-02-01       Impact factor: 4.849

8.  Amyotrophic lateral sclerosis. A study of its presentation and prognosis.

Authors:  S S Gubbay; E Kahana; N Zilber; G Cooper; S Pintov; Y Leibowitz
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

Review 9.  Cost effectiveness of treatments for amyotrophic lateral sclerosis: a review of the literature.

Authors:  Gary Ginsberg; Serena Lowe
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

Review 10.  Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis.

Authors:  Benoît Marin; Farid Boumédiene; Giancarlo Logroscino; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Massimilano Copetti; Pierre-Marie Preux; Ettore Beghi
Journal:  Int J Epidemiol       Date:  2017-02-01       Impact factor: 7.196

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.